Roche's Trontinemab Raises the Bar for Alzheimer's Amyloid Clearance Alzheimer’s disease treatments may be on the cusp of a major breakthrough, thanks to Roche’s innovative antibody, trontinemab . This next-generation therapy has shown remarkable speed and effectivenes... Alzheimer’s amyloid plaques blood-brain barrier clinical trials drug development neurodegeneration trontinemab